Research Network

Middle East / GCC

Hekma Clinical research is a regional Clinical research organization. We know the native investigators and the local regulatory process in different countries. Having a broad network of researchers in countries located in MENA and Gulf region, we can manage multicenter studies in parallel with the multinational companies across the world. This network makes it possible and facilitates conducting international research projects professionally.

Middle East

GCC

A Promising Hub for Global Multicenter Clinical Research

The Middle East, with its diverse population and unique genetic characteristics, presents a remarkable opportunity for conducting global multicenter clinical research. Countries in this region are increasingly becoming focal points for the pharmaceutical and biotechnology industries. This surge can be attributed to several factors that enhance the feasibility and effectiveness of clinical trials:

Diverse Population and Global Representation

The Middle East includes a variety of cultures and ethnicities, making it an ideal setting for clinical research that seeks to capture diverse genetic backgrounds. Countries such as Saudi Arabia, United Arab Emirates (UAE), Egypt, Qatar, and Oman boast populations characterized by significant genetic diversity, which can lead to more comprehensive insights into disease mechanisms and treatment responses. This genetic richness increases the generalizability of research findings across different populations.

Regulatory Framework and Supportive Infrastructure

Many Middle Eastern countries are actively working to improve their regulatory frameworks, making them more conducive to clinical trials. For instance, the Saudi Food and Drug Authority (SFDA) and the UAE's Ministry of Health and Prevention have streamlined their approval processes for clinical research, fostering a more efficient environment for study initiation. Furthermore, the establishment of Clinical Research Organizations (CROs) in countries like Oman enhances the capacity for managing and conducting clinical trials, offering expertise and local knowledge.

Access to Healthcare Facilities and Expertise

The region is home to a growing number of world-class healthcare institutions equipped with advanced technology and facilities. Countries such as Qatar and the UAE have made significant investments in healthcare, which has translated into a strong network of hospitals and clinics capable of supporting clinical trials. This infrastructure is complemented by a well-educated workforce of healthcare professionals, including doctors and researchers, who are committed to high-quality care and scientific advancement.

Government Initiatives and Economic Growth

Governments in the Middle East are increasingly recognizing the importance of clinical research in improving healthcare outcomes and driving economic growth. Initiatives aimed at promoting medical research, like the Oman Vision 2040 and investments in clinical research sectors, reflect a commitment to becoming global leaders in this field. By fostering partnerships between public and private sectors, these countries are actively encouraging both local and international sponsors to launch clinical trials in the region.

Given its unique demographic, rich genetic diversity, evolving regulatory landscape, and robust healthcare infrastructure, the Middle East is poised to become a significant player in global multicenter clinical research. As we establish our CRO in Oman, we aim to leverage these strengths to create a comprehensive network across Middle Eastern countries, facilitating efficient, high-quality clinical trials that cater to a wide array of global health needs. We invite partners and stakeholders to join us in harnessing the vast potential of this region to advance clinical research worldwide.